Animals, 2022 The purpose of the present study was to test whether the addition of cisatracurium in combination with propofol and sevoflurane would result in a change in doses of used anesthetic drugs.
Claudia Interlandi +7 more
doaj +2 more sources
How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
Annals of Intensive Care, 2017 Background Neuromuscular blocking agents (NMBAs) have been shown to improve the outcome of the most severely hypoxemic, acute respiratory distress syndrome (ARDS) patients.
Sami Hraiech +11 more
doaj +2 more sources
The effect of cisatracurium infusion on the energy expenditure of critically ill patients: an observational cohort study [PDF]
Critical Care, 2020 Background Both overfeeding and underfeeding of intensive care unit (ICU) patients are associated with worse outcomes. A reliable estimation of the energy expenditure (EE) of ICU patients may help to avoid these phenomena.
W. A. C. Koekkoek +4 more
doaj +2 more sources
Effect of nitrous oxide on cisatracurium infusion demands: a randomized controlled trial [PDF]
BMC Anesthesiology, 2010 Background Recent studies have questioned our previous understanding on the effect of nitrous oxide on muscle relaxants, since nitrous oxide has been shown to potentiate the action of bolus doses of mivacurium, rocuronium and vecuronium.
Illman Hanna L +2 more
doaj +3 more sources
Prospective Cohort Study Comparing Varying Doses of Cisatracurium and Atracurium on Intubating Conditions in Patients Undergoing Laparoscopic Cholecystectomy [PDF]
Journal of Clinical and Diagnostic Research, 2021 Introduction: Cisatracurium and atracurium are nondepolarising muscle relaxants belonging to benzylisoquinolinium group. Intubating dose of cisatracurium is found to be safer than atracurium owing to the histamine release and resultant respiratory and
Chandrasekharan Anjali +2 more
doaj +1 more source
Comparison of Different Neostigmine Doses for Reversal of Cisatracurium-Induced Neuromuscular Block in Children Under Total Intravenous Anesthesia: A Randomized Controlled Trial. [PDF]
Paediatr AnaesthABSTRACT Background Neostigmine is widely used to reverse nondepolarizing neuromuscular blockade in children, but the optimal dose under total intravenous anesthesia is uncertain. Aims The primary aim was to compare the time to full neuromuscular recovery (TOF ratio of 1.0) following administration of neostigmine at doses of 0, 10, 20, and 30 μg/kg in ...
Neto AJMM +7 more
europepmc +2 more sources
Polarized Light Microscopy for Quantitative Assessment of Sarcomere-Scale Structural Order in Cardiac Tissue. [PDF]
J BiophotonicsImpact of cardiac and respiratory arrest on cardiac muscle tissue. Wistar rats were injected (on the left) either with cisatracurium to induce a respiratory arrest or lidocaine to induce a cardiac arrest (in the middle). Further, the pathophysiological changes developed and were assessed with linear polarization microscopy at 600–3000 nm wavelength ...
Piavchenko G +12 more
europepmc +2 more sources
Cisatracurium – A “safe” neuromuscular blocking agent? [PDF]
, 2022 Anesthetic agents are an important cause of drug anaphylaxis, with neuromuscular blocking agents (NMBA) being a common cause of intraoperative anaphylaxis.
Gonçalves, Tânia +4 more
core +1 more source
Antagonist of Chrna1 prevents the pathogenesis of primary focal hyperhidrosis
Annals of Clinical and Translational Neurology, 2022 Background Primary focal hyperhidrosis (PFH) is an autonomic neurological disease in which exocrine glands are oversecreted due to autonomic dysfunction of the sympathetic nervous system. Chrna1 promotes the pathogenesis of PFH.
Jian‐Bo Lin +3 more
doaj +1 more source
Pharmaceutics, 2023 Background: Stability study of a 10 mg/mL injectable cisatracurium solution stored refrigerated in amber glass ampoules for 18 months (M18). Methods: 4000 ampoules were aseptically compounded using European Pharmacopoeia (EP)-grade cisatracurium besylate,
Marine Roche +7 more
doaj +1 more source